Adar1 Capital Management, LLC: holdings and changes
Number 86 of the top 100 funds by copy return. Adar1 Capital Management, LLC reported 255 US stocks worth $2.2B for the quarter ending 2026-09-30 and changed 41 new, 68 added, 52 trimmed and 40 sold since 2026-06-30.
Copy return, 4 quarters+35.9%
US 500, same time+14.5%
Size$2.2B
Stocks255
Holdings
| Stock | Change | Weight | Value | Shares |
|---|---|---|---|---|
| ABVX Abivax Sa-Adr | ADD +14% | 9.43% | $203M | 2,050,822 |
| SPDRS Spdrs | ADD +38% | 6.29% | $136M | 177,624 |
| PTGX Protagonist Therapeutics INC | 6.22% | $134M | 951,403 | |
| ROIV Roivant Sciences LTD | 5.23% | $113M | 3,079,526 | |
| IMVT Immunovant INC | TRIM -9% | 3.32% | $72M | 2,115,502 |
| DNLI Denali Therapeutics INC | ADD +101% | 1.99% | $43M | 2,072,050 |
| EA SERIES TRUS Ea Series Trust | 1.85% | $40M | 337,125 | |
| SEPN Septerna INC | ADD +4% | 1.77% | $38M | 974,396 |
| AGIO Agios Pharmaceuticals INC | TRIM -12% | 1.76% | $38M | 1,139,464 |
| AURA Aura Biosciences INC | ADD +4038% | 1.57% | $34M | 5,385,879 |
| VKTX Viking Therapeutics INC | ADD +80% | 1.57% | $34M | 1,034,749 |
| CYTK Cytokinetics INC. | 1.41% | $30M | 461,407 | |
| INSM Insmed INC. | 1.22% | $26M | 229,531 | |
| FRNM Freenome INC | BUY | 1.20% | $26M | 1,645,800 |
| CLDX Celldex Therapeutics INC | ADD +29% | 1.20% | $26M | 799,304 |
| AVR Anteris Technologies Global | 1.17% | $25M | 3,237,321 | |
| BBIO Bridgebio Pharma INC | ADD +115% | 1.16% | $25M | 379,261 |
| PRAX Praxis Precision Medicines I | ADD +14% | 1.15% | $25M | 84,751 |
| FULC Fulcrum Therapeutics INC | ADD +325% | 1.14% | $25M | 6,648,027 |
| VIR Vir Biotechnology INC | TRIM -12% | 1.12% | $24M | 2,158,839 |
| DBVT Dbv Technologies S A | ADD +281% | 1.10% | $24M | 2,010,831 |
| ENTA Enanta Pharmaceuticals INC | ADD +29% | 1.06% | $23M | 1,733,320 |
| EDIT Editas Medicine INC | 1.06% | $23M | 8,889,000 | |
| AEGLEA BIOTHER Aeglea Biotherapeutics INC | TRIM -16% | 0.98% | $21M | 237,567 |
| ELVN Enliven Therapeutics INC | ADD +14% | 0.94% | $20M | 442,682 |
| NRIX Nurix Therapeutics INC | ADD +160% | 0.90% | $19M | 813,236 |
| SNY Sanofi Adr | ADD +714% | 0.89% | $19M | 464,600 |
| RVMD Revolution Medicines INC | 0.83% | $18M | 87,509 | |
| SRPT Sarepta Therapeutics INC | ADD +30% | 0.81% | $17M | 952,063 |
| MAZE Maze Therapeutics | ADD +88% | 0.80% | $17M | 637,353 |
| ANL Adlai Nortye LTD | 0.74% | $16M | 997,356 | |
| RLYB Rallybio Corp Com | 0.74% | $16M | 926,352 | |
| NKTR Nektar Therapeutics | ADD +6% | 0.73% | $16M | 258,182 |
| URGN Urogen Pharma LTD | ADD +47% | 0.70% | $15M | 369,785 |
| TSHA Taysha Gene Therapies INC Com Shs | 0.69% | $15M | 3,059,567 | |
| MNPR Monopar Therapeutics INC | TRIM -18% | 0.66% | $14M | 179,032 |
| JANX Janux Therapeutics INC. | ADD +96% | 0.66% | $14M | 823,876 |
| RYTM Rhythm Pharmaceuticals INC | 0.61% | $13M | 138,658 | |
| PRTA Prothena Corp PLC | 0.59% | $13M | 1,522,103 | |
| COGT Cogent Biosciences INC | ADD +3117% | 0.58% | $13M | 392,422 |
| REGN Regeneron Pharmaceuticals INC Com | TRIM -26% | 0.58% | $12M | 16,446 |
| SPDR SER TR Spdr Ser Tr | 0.58% | $12M | 135,585 | |
| TENX Tenax Therapeutics INC | ADD +284% | 0.57% | $12M | 6,524,151 |
| GLUE Monte Rosa Therapeutics INC | ADD +365% | 0.56% | $12M | 1,007,752 |
| ABCL Abcellera Biologics INC | BUY | 0.56% | $12M | 822,163 |
| ESTA Establishment Labs Hldgs INC | 0.55% | $12M | 185,619 | |
| VOGX Vogenx INC | BUY | 0.55% | $12M | 522,175 |
| IKT Inhibikase Therapeutics INC | TRIM -23% | 0.54% | $12M | 5,708,755 |
| OVID Ovid Therapeutics INC | TRIM -39% | 0.53% | $11M | 4,560,813 |
| AVLN Avalyn Pharma INC | ADD +172% | 0.53% | $11M | 397,719 |
| TEVA Teva Pharmaceutical-Sp Adr | BUY | 0.51% | $11M | 276,348 |
| AMLX Amylyx Pharmaceuticals INC Com | TRIM -26% | 0.50% | $11M | 366,968 |
| HLXC Helix Acquisition Corp III | 0.49% | $11M | 1,000,000 | |
| BEAM Beam Therapeutics INC | BUY | 0.48% | $10M | 420,981 |
| VOR Vor Biopharma INC | TRIM -22% | 0.47% | $10M | 531,349 |
| EWTX Edgewise Therapeutics INC | ADD +70% | 0.46% | $10M | 243,199 |
| KZIA Kazia Therapeutics LTD | ADD +1472% | 0.43% | $9M | 967,740 |
| ELIEM THERAPEU Eliem Therapeutics INC | TRIM -4% | 0.42% | $9M | 792,936 |
| REPL Replimune Group INC | 0.40% | $9M | 655,784 | |
| OCUPHIRE PHARM Ocuphire Pharma INC | 0.40% | $9M | 1,783,781 | |
| SMMT Summit Therapeutics | ADD +159% | 0.39% | $8M | 496,965 |
| PCVX Vaxcyte INC | 0.39% | $8M | 146,034 | |
| RACC Research Alliance Corp III | ADD +18% | 0.39% | $8M | 767,000 |
| AMAN Amanat Acquisition Corp | 0.37% | $8M | 750,000 | |
| JATT Jatt II Acquisition Corp | ADD +64% | 0.36% | $8M | 683,022 |
| ENTX Entera Bio LTD | BUY | 0.35% | $8M | 2,625,980 |
| IVA Inventiva Sa | TRIM -43% | 0.35% | $8M | 2,066,330 |
| RNAQ Rainier Acquisition Corp | BUY | 0.35% | $8M | 742,500 |
| IONS Ionis Pharmaceuticals INC | 0.35% | $8M | 169,593 | |
| CCCC C4 Therapeutics INC | ADD +665% | 0.35% | $7M | 2,232,857 |
| MPLT Maplight Therapeutics INC | ADD +2637% | 0.34% | $7M | 725,165 |
| SVRA Savara INC | 0.34% | $7M | 1,410,409 | |
| CATX Perspective Therapeutics INC | ADD +116% | 0.33% | $7M | 2,617,870 |
| SLN Silence Therapeutics PLC | ADD +86% | 0.32% | $7M | 629,654 |
| BHVN Biohaven LTD | 0.31% | $7M | 501,687 | |
| ASND Ascendis Pharma A/S | 0.30% | $6M | 28,604 | |
| DXYZ Destiny Tech100 INC | BUY | 0.30% | $6M | 210,399 |
| YARW Yarrow Bioscience INC | BUY | 0.30% | $6M | 282,996 |
| TCGX Tcgx Acquisition Corp | BUY | 0.29% | $6M | 500,374 |
| RACD Research Alliance Corp Iv | BUY | 0.29% | $6M | 525,234 |
| ZLAB Zai Lab Limited Adr | SELL | 0% | was $64M | 0 |
| CRINETICS PHAR Crinetics Pharmaceuticals In | SELL | 0% | was $46M | 0 |
| XENE Xenon Pharmaceuticals INC | SELL | 0% | was $10M | 0 |
| TEVA Teva Pharm Inds LTD Adrf Spons | SELL | 0% | was $9M | 0 |
| SENSEI BIOTHER Sensei Biotherapeutics INC | SELL | 0% | was $9M | 0 |
| GALECTO INC Galecto INC | SELL | 0% | was $7M | 0 |
| PERCEPTIVE CAP Perceptive Cap Solutions Cor | SELL | 0% | was $7M | 0 |
| BHF Brighthouse Finl INC Com | SELL | 0% | was $6M | 0 |
| DGAC Disciplined Growth | SELL | 0% | was $5M | 0 |
| PRLD Prelude Therapeutics INC | SELL | 0% | was $5M | 0 |
| ATAI BECKLEY N Atai Beckley Nv | SELL | 0% | was $5M | 0 |
| APOGEE THERA I Apogee Thera INC | SELL | 0% | was $4M | 0 |
| XNCR Xencor INC | SELL | 0% | was $4M | 0 |
| SGMT Sagimet Biosciences INC. | SELL | 0% | was $3M | 0 |
| ZNTL Zentalis Pharmaceuticals INC | SELL | 0% | was $3M | 0 |
| OABI Omniab INC | SELL | 0% | was $2M | 0 |
| ORKA Oruka Therapeutics INC | SELL | 0% | was $2M | 0 |
| MCK Mckesson Corporation Com | SELL | 0% | was $2M | 0 |
| VYNE THERAPEUT Vyne Therapeutics INC | SELL | 0% | was $2M | 0 |
| AVTR Avantor INC | SELL | 0% | was $1M | 0 |
| MTRI Inmed Pharmaceuticals INC | SELL | 0% | was $1M | 0 |
| CYCLERION THER Cyclerion Therapeutics INC Com | SELL | 0% | was $1M | 0 |
| DYN Dyne Therapeutics INC | SELL | 0% | was $1M | 0 |
| ELECTRONIC ART Electronic Arts Com | SELL | 0% | was $1M | 0 |
| ACADIA PHARMAC Acadia Pharmacutical INC | SELL | 0% | was $1M | 0 |
| NUVALENT INC Nuvalent INC | SELL | 0% | was $900k | 0 |
| WVE Wave Life Sciences LTD | SELL | 0% | was $900k | 0 |
| ADGM Adagio Medical Holdings INC | SELL | 0% | was $800k | 0 |
| FWRD Forward Air Corp Com | SELL | 0% | was $700k | 0 |
| IOVA Iovance Biotherapeutics INC | SELL | 0% | was $600k | 0 |
| SYK Stryker Corp | SELL | 0% | was $600k | 0 |
| CYBIN INC Cybin INC | SELL | 0% | was $500k | 0 |
| KIDS Orthopediatrics Corp | SELL | 0% | was $500k | 0 |
| WT Wisdomtree Tr | SELL | 0% | was $500k | 0 |
| BNTC Benitec Biopharma INC | SELL | 0% | was $500k | 0 |
| MRK Merck Co INC New Com | SELL | 0% | was $400k | 0 |
| WW Ww Intl INC | SELL | 0% | was $300k | 0 |
| PSNL Personalis INC | SELL | 0% | was $200k | 0 |
| QCLS Q/C Technologies INC | SELL | 0% | was $200k | 0 |
| ANAB Anaptysbio INC | SELL | 0% | was $200k | 0 |
Copy return each quarter
| Held | Fund copy | US 500 |
|---|---|---|
| 2024-06-30 → 2024-09-30 | +11.3% | +5.4% |
| 2024-09-30 → 2024-12-31 | -6.8% | +2.1% |
| 2024-12-31 → 2025-03-31 | -5.1% | -4.6% |
| 2025-03-31 → 2025-06-30 | +3.9% | +10.5% |
| 2025-06-30 → 2025-09-30 | +25.7% | +7.8% |
| 2025-09-30 → 2025-12-31 | +20.7% | +2.4% |
| 2025-12-31 → 2026-03-31 | +3.5% | -4.6% |
| 2026-03-31 → 2026-06-30 | +17.5% | +14.8% |
| 2026-06-30 → 2026-09-30 | -7.4% | +2.1% |
The copy return buys the fund's reported stocks on the day after the filing became public and holds them for one quarter, so it measures what anyone reading the filings could have done.
All top 100 funds, liveOther top funds
Nextech Invest LTD.Venrock Adviser, LLCFairmount Funds Management LLCTalos Eurisko Asset Management LPAnalog Century Management LPQvt Financial LPBroad Peak Investment Advisers Pte LTDWs Management LllpBvf INC/IlParadigm Biocapital Advisors LPOak Grove Capital LLCCm Wealth Advisors LLCAvidity Partners Management LPFirst Light Asset Management, LLCLogos Global Management LPSummit Street Capital Management, LLCMadison Avenue Partners, LPDivisar Capital Management LLCTcg Crossover Management, LLCOptimus Prime Fund Management Co., LTD.Value Aligned Research Advisors, LLCBraidwell LPRedmile Group, LLCOrbimed Advisors LLCMpm Bioimpact LLCCloudalpha Capital Management Limited/Hong KongGeneral Pension Society Pzu Joint Stock CoAmanah Holdings TrustSlate Path Capital LPDeep Track Capital, LP